Nucala significantly relieves moderate to severe discomfort in chronic obstructive pulmonary disease

Results from the MATINEE trial found that Nucala produced a statistically significant and clinically meaningful reduction in moderate/severe exacerbations of chronic obstructive pulmonary disease compared to placebo over 104 weeks.